Should We Be Concerned With IM Cannabis' Financials After reviewing the IM Cannabis financial statements, having them takeover MYM is not a good idea.
In fact, when I went over the IM Cannabis Financial Statements, while they revenues have gone up, they haven't turned a profit as they incurred a $5 million loss.
Logically speaking, when sales go up, IM Cannabis should be turning a profit, not a $5 million loss.
Now you know why MYM Nutraceuticals investors should say NO to the IM Cannabis takeover, especially when the latter is incurring more losses as opposed to a profit.